| [1] |
Raia S, Nery JR, Mies S. Liver transplantation from live donors[J]. Lancet, 1989, 2(8661):497.
|
| [2] |
Wong TCL, Fung JYY, Pang HH, et al. Analysis of survival benefits of living versus deceased donor liver transplant in high model for end-stage liver disease and hepatorenal syndrome[J]. Hepatology, 2021, 73(6):2441-2454.
|
| [3] |
Taniguchi M, Shimamura T, Todo S, et al. Small-for-size syndrome in living-donor liver transplantation using a left lobe graft[J]. Surg Today, 2015, 45(6):663-671.
|
| [4] |
Masuda Y, Yoshizawa K, Ohno Y, et al. Small-for-size syndrome in liver transplantation: definition, pathophysiology and management[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(4):334-341.
|
| [5] |
Kamo N, Kaido T, Hammad A, et al. Impact of elderly donors for liver transplantation: a single-center experience[J]. Liver Transpl, 2015, 21(5):591-598.
|
| [6] |
Macshut M, Kaido T, Yao S, et al. Older donor age is a risk factor for negative outcomes after adult living donor liver transplantation using small-for-size grafts[J]. Liver Transpl, 2019, 25(10):1524-1532.
|
| [7] |
Chu MJ, Dare AJ, Phillips AR, et al. Donor hepatic steatosis and outcome after liver transplantation: a systematic review[J]. J Gastrointest Surg, 2015, 19(9):1713-1724.
|
| [8] |
Starzl TE, Putnam CW, Groth CG, et al. Alopecia, ascites, and incomplete regeneration after 85 to 90 percent liver resection[J]. Am J Surg, 1975, 129(5):587-590.
|
| [9] |
Soejima Y, Taketomi A, Yoshizumi T, et al. Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases[J]. Am J Transplant, 2006, 6(5 Pt 1): 1004-1011.
|
| [10] |
Rajakumar A, Kaliamoorthy I, Rela M, et al. Small-for-size syndrome: bridging the gap between liver transplantation and graft recovery[J]. Semin Cardiothorac Vasc Anesth, 2017, 21(3):252-261.
|
| [11] |
Okamura Y, Yagi S, Sato T, et al. Coexistence of bilirubin≥10 mg/dLand prothrombin time-international normalized ratio≥1.6 on day 7: a strong predictor of early graft loss after living donor liver transplantation[J]. Transplantation, 2018, 102(3):440-447.
|
| [12] |
Soejima Y, Shirabe K, Taketomi A, et al. Left lobe living donor liver transplantation in adults[J]. Am J Transplant, 2012, 12(7):1877-1885.
|
| [13] |
Sánchez-Cabús S, Cherqui D, Rashidian N, et al. Left-liver adult-to-adult living donor liver transplantation: can it be improved? a retrospective multicenter European study[J]. Ann Surg, 2018, 268(5):876-884.
|
| [14] |
Orue-Echebarria MI, Lozano P, Olmedilla L, et al. "Small-for-flow" syndrome: concept evolution[J]. J Gastrointest Surg, 2020, 24(6):1386-1391.
|
| [15] |
Hibi T, Kitagawa Y. Small-for-size syndrome in LT[J]. Clin Liver Dis, 2017, 10(4):93-96.
|
| [16] |
Firl DJ, Hashimoto K, O'Rourke C, et al. Impact of donor age in liver transplantation from donation after circulatory death donors: a decade of experience at Cleveland Clinic[J]. Liver Transpl, 2015, 21(12):1494-1503.
|
| [17] |
Yagi S, Iida T, Hori T, et al. Effect of portal haemodynamics on liver graft and intestinal mucosa after small-for-size liver transplantation in swine[J]. Eur Surg Res, 2012, 48(3):163-170.
|
| [18] |
Hong BJ, Liu H, Wang ZH, et al. Inflammasome activation involved in early inflammation reaction after liver transplantation[J]. Immunol Lett, 2017(190):265-271.
|
| [19] |
Brockmann L, Soukou S, Steglich B, et al. Molecular and functional heterogeneity of IL-10-producing CD4+ T cells[J]. Nat Commun, 2018, 9(1):5457.
|
| [20] |
Piccirillo CA, Shevach EM. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance[J]. Semin Immunol, 2004, 16(2):81-88.
|
| [21] |
Feng Y, Han Z, Feng Z, et al. Approaching treatment for immunological rejection of living-donor liver transplantation in rats[J]. BMC Gastroenterol, 2020, 20(1):7.
|
| [22] |
Yoshizumi T, Itoh S, Shimokawa M, et al. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation[J].J Hepatol, 2021, 74(2):372-379.
|
| [23] |
Ito K, Akamatsu N, Ichida A, et al. Splenectomy is not indicated in living donor liver transplantation[J]. Liver Transpl, 2016, 22(11):1526-1535.
|
| [24] |
Nguyen JH, Harnois DM. Allograft portacaval shunt in small-for-size liver in deceased donor liver transplant[J]. Transplant Proc, 2018, 50(3):930-932.
|
| [25] |
Troisi RI, Berardi G, Tomassini F, et al. Graft inflow modulation in adult-to-adult living donor liver transplantation: a systematic review[J]. Transplant Rev, 2017, 31(2):127-135.
|
| [26] |
Wei W, Hua C, Zhang T, et al. Size of portally deprived liver lobe after portal vein ligation and additional partial hepatectomy: result of balancing proliferation and apoptosis[J]. Sci Rep, 2020, 10(1):4893.
|
| [27] |
Guo HJ, Wang K, Chen KC, et al. Middle hepatic vein reconstruction in adult right lobe living donor liver transplantation improves recipient survival[J]. Hepatobiliary Pancreat Dis Int, 2019, 18(2):125-131.
|
| [28] |
Cattral MS, Molinari M, Vollmer CM Jr, et al. Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patients[J]. Am J Transplant, 2004, 4(5):751-757.
|
| [29] |
Miyazawa K, Miyagi S, Nakanishi C, et al. Effect of middle hepatic vein tributaries preserving technique until just before graft retrieval on donors' surgical outcomes in living donor liver transplantation[J]. Transplant Proc, 2018, 50(9):2636-2639.
|
| [30] |
Grut H, Solberg S, Seierstad T, et al. Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases[J]. Br J Surg, 2018, 105(3):295-301.
|
| [31] |
Feng Y, Han Z, Gu B, et al. A novel method for the prevention and treatment of small-for-size syndrome in liver transplantation[J]. Dig Dis Sci, 2020, 65(9):2619-2629.
|
| [32] |
Kelly DM, Zhu X, Shiba H, et al. Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome[J]. Liver Transpl, 2009, 15(11):1448-1457.
|
| [33] |
Tang LM, Wang YP, Wang K, et al. Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation[J]. Transpl Int, 2007, 20(1):93-101.
|
| [34] |
Mohkam K, Darnis B, Schmitt Z, et al. Successful modulation of portal inflow by somatostatin in a porcine model of small-for-size syndrome[J]. Am J Surg, 2016, 212(2):321-326.
|
| [35] |
Du Z, Zhou Y, Lu X, et al. Octreotide prevents liver failure through upregulating 5'-methylthioadenosine in extended hepatectomized rats[J]. Liver Int, 2016, 36(2):212-222.
|